The Gene Therapy Toolbox: AAV
Date/Time: Monday, October 5, 2020 - 12:00 PM – 1:00 PM
Track: Interactive Lunch Workshop
Room: San Gabriel B
Log in to Add to My Schedule
Following the approval of the first gene therapy for a neurological disease, a growing number of clinical trials predicts additional approvals in the next decade, most using AAV as a vehicle. Neurologists should familiarize with the status of the field for these “one and done” therapies.
To understand the biology of AAV, repertoire of capsids, species specificity and immune responses.
To learn the different AAV-driven therapeutic strategies available
To identify currently approved and emerging AAV-based therapies for neurological diseases.